HCV
Clinical trials for HCV explained in plain language.
Never miss a new study
Get alerted when new HCV trials appear
Sign up with your email to follow new studies for HCV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Timing is everything: new trial aims to prevent hepatitis c in kidney transplants
Disease control Recruiting nowThis study looks at the best time to give Hepatitis C (HCV) medication to people without HCV who receive a kidney from a donor with HCV. One group starts the medicine before transplant and takes it for 2 weeks; the other starts after transplant and takes it for 12 weeks. The goal…
Matched conditions: HCV
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
One drop, four diseases: new rapid test aims to transform screening in africa
Diagnosis Recruiting nowThis study evaluates a new point-of-care test called MagIA H3S that can detect HIV, hepatitis B, hepatitis C, and syphilis from a single blood sample. Researchers will test about 2,950 people in Ivory Coast and Kenya to see how accurate the device is compared to standard lab test…
Matched conditions: HCV
Sponsor: MagIA Diagnostics • Aim: Diagnosis
Last updated May 26, 2026 03:33 UTC
-
Peer navigators + smartphone app aim to boost HIV/STI testing in rural appalachia
Prevention Recruiting nowThis study combines peer navigation (trained community members) with a mobile health app to help gay, bisexual, and transgender people in rural Appalachia access HIV, STI, and hepatitis C testing and prevention services. About 141 participants will be split into two groups: one g…
Matched conditions: HCV
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Prevention
Last updated May 26, 2026 03:27 UTC
-
Baltimore study uses hotspot mapping to stop HIV and overdose in drug users
Prevention Recruiting nowThis pilot study aims to reduce HIV, hepatitis C, and overdose risks among people who inject drugs in Baltimore. Researchers will identify high-risk locations and use peer-driven outreach to promote carrying naloxone and avoiding shared equipment. About 285 current drug users wil…
Matched conditions: HCV
Phase: NA • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Prevention
Last updated May 26, 2026 03:05 UTC
-
Gut check: new study probes how hepatitis drug changes your microbiome
Knowledge-focused Recruiting nowThis study tracks 20 adults with chronic hepatitis delta (a serious liver infection) who are starting a new drug called bulevirtide. Researchers want to see how the drug changes the gut's bacteria and bile acids over 48 weeks, and how those changes relate to inflammation and live…
Matched conditions: HCV
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC